News

Industries

Companies

Jobs

Events

People

Video

Audio

Galleries

Submit content

My Account

Advertise with us

Subscribe & Follow

Advertise your job vacancies
    Search jobs

    Obesity Drug Linked to Suicidal Thoughts

    The manufacturer of the antiobesity drug rimonobant, sold under the Acomplia brand, has informed the FDA that users of the medication suffer from a higher risk of suicidal thoughts. Sanofi-Aventis also told the FDA that it doesn't recommend the drug for people who suffer from depression.

    Sanofi-Aventis has told the U.S. Food and Drug Administration its rimonobant antiobesity drug, also sold under the Acomplia brand, brings a higher risk of suicidal thoughts than placebo, and it does not recommend the treatment for patients suffering from major depression.

    Read the full article

    More news
    Let's do Biz